Suraksha Diagnostic Limited announced the acquisition of 8,200 equity shares through an open market purchase on August 14, 2025. This acquisition increased the promoter's holding, Dr. Somnath Chatterjee, to 5.082% of the total share/voting capital.
The shares were acquired by Dr. Somnath Chatterjee, Promoter, Chairman & Joint Managing Director of Suraksha Diagnostic Limited, and the disclosure was made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
| Particulars | Before Acquisition | Acquisition | After Acquisition |
|---|---|---|---|
| Shares carrying voting rights | 26,38,768 | 8,200 | 26,46,968 |
| % w.r.t. total share/voting capital | 5.067% | 0.016% | 5.082% |
| % w.r.t. total diluted share/voting capital of the TC | 5.067% | 0.016% | 5.082% |
Prior to the acquisition, Dr. Chatterjee held 2,638,768 shares, representing 5.067% of the total share/voting capital. Following the acquisition of 8,200 shares, his holding increased to 2,646,968 shares, representing 5.082% of the total share/voting capital.
The equity share capital of Suraksha Diagnostic Limited before and after the acquisition remained at ₹10,41,61,516, consisting of 5,20,80,758 equity shares of ₹2 each.
The acquisition was executed through an open market purchase on August 14, 2025.
Dr. Somnath Chatterjee, Promoter, Chairman & Joint Managing Director of Suraksha Diagnostic Limited, signed the disclosure.
The acquisition was executed through an open market purchase.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
